Monarch LifeSciences is a contract research organization specializing in protein biomarker discovery, development, and validation.

AverDx is discovering and developing novel biomarker diagnostics for critical diseases that improve clinical outcomes and save healthcare resources.

Our Proteomics software, ProteoIQ, is the most advanced software for comparative and quantitative proteomics.

Calibrant's Gemini drug discovery platform is pioneering targeted proteomic analysis for the diagnosis and treatment of cancer.

Bruker BioSpin is the market leader in NMR spectroscopy, EPR, and pre-clinical MRI. BioSpin offers the world's most comprehensive biotechnology range of life ...

MbMD Multivariate Biomarkers Discovery

BioVisioN's Peptidomics summarises technologies for the analysis and visualisation of native peptides and small proteins from biological samples. One key ...

Oxford BioTherapeutics: Providing solutions through Protein Biomarker Discovery. Oxford BioTherapeutics offers services for biomarker discovery and ...

Vital Probes, Inc. is a developer of rapid detection systems and vaccines for infectious agents utilizing cutting edge proteomics and genomics based ...